JAMA Medical News cover image

April 2023 Medical News Summary

JAMA Medical News

00:00

The Risks of Simagletide for Weight Loss

The branded version of semagletide known as ozempic has been making headlines because of its ability to aid with weight loss. The drug is actually sold under three brand names, ozempic, rebalcis and we govi. They're all essentially the same drug, but they're sold in different forms with different doses and different indications.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app